Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice

@inproceedings{Cubells2013EffectivenessOD,
  title={Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice},
  author={Daniel Almenar Cubells and Carlos E Bosch Roig and E Jim{\'e}nez Orozco and Ruth {\'A}lvarez and JM Cuervo and Nieves D{\'i}az Fern{\'a}ndez and AB S{\'a}nchez Heras and Antonio Gal{\'a}n Brotons and Vicente Giner Marco and M Codes M De Villena},
  booktitle={European journal of cancer care},
  year={2013}
}
We conducted a multicentre, retrospective, observational study including patients with solid tumours (excluding breast cancer) that received granulocyte colony-stimulating factors (G-CSF) and chemotherapy. We investigated the effectiveness of daily vs. non-daily G-CSFs (pegfilgrastim) adjusting by potential confounders. The study included 391 patients (211 daily G-CSF; 180 pegfilgrastim), from whom 47.3% received primary prophylaxis (PP) (57.8% pegfilgrastim), 26.3% secondary prophylaxis (SP… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners • 2018
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 46 references

Current practice of prophylaxis with granulocyte colony-stimulating

J. Marina, F. J. Carabantes, +7 authors S. Menjón
2009
View 1 Excerpt

Febrile neutropenia and related complications in breast cancer patients

G. Von Minckwitz, M. Schwenkglenks, +5 authors M. S. Aapro
2009

Multi - variate analysis of febrile neutropenia occurrence in patients with non - Hodgkin lymphoma : data from the INC - EU Prospective Observational European Neutropenia Study

L. Pinto, Z. Liu, +3 authors G. Lyman
British Journal of Haematology • 2009

Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2008
View 2 Excerpts

Evaluación económica del uso de pegfilgrastim frente a filgrastim en profilaxis primaria en

J.I.M. Cámara, A. L. Pousa, +5 authors R. Arocho
2008
View 1 Excerpt

Similar Papers

Loading similar papers…